Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RF vs Chemical Neurolysis for Abdominal Cancer Pain
NCT03063112Unknown
- Sponsor
- South Egypt Cancer Institute
- Start
- Oct 2016
- Primary completion
- Apr 2017
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by South Egypt Cancer Institute. Primary endpoint: Pain relief at 3 months. Status: unknown.
Beyond the preview
Go deeper on NCT03063112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03063112.